Impact of Ambulatory Management for Primary Spontaneous Pneumothorax in the Emergency Department on Quality of Life
EFFI-PNO
1 other identifier
interventional
386
1 country
7
Brief Summary
Outpatient treatment of Primary Spontaneous Pneumothorax (PSP) compared to usual inpatient management could improve quality of care and represent a more efficient, generalizable and sustainable strategy. This multicenter, cluster-controlled, randomized interventional study with stepped wedge implementation will evaluate the impact on quality of life (between inclusion, after drain placement, and 6 months) of an ambulatory strategy for the management of large abundance primary spontaneous pneumothorax in the emergency department, compared with usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Longer than P75 for not_applicable
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2024
CompletedFirst Posted
Study publicly available on registry
June 24, 2024
CompletedStudy Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2030
November 26, 2025
November 1, 2025
4.6 years
June 14, 2024
November 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quality of life at 6 months
Evaluate the impact on quality of life (between inclusion, after drain placement, and 6 months) of an ambulatory strategy for the management of large abundance primary spontaneous pneumothorax in the emergency department, compared with usual care, using the Short Form (36) Health Survey (The lower the score the more disability)
6 months
Secondary Outcomes (23)
Success rate of the strategy as measured by pulmonary expansion (lung reattachment on X-ray / CT scan) the latest by the investigator who performed the drainage procedure
Day 6
Proportion of patients having benefited from an exclusive outpatient management (patients not requiring hospitalisation during the ambulatory approach)
Day 6
Assessment of Pain
Day 0, Day 2, Day 4, Day 6 and monthly
Assessment of Dyspnea according to the mMRC classification
Day 0, Day 2, Day 4, Day 6 and monthly
Complication rates (major and minor) in the 2 groups
Day 2, 4, 6, 1 month and 1 year
- +18 more secondary outcomes
Study Arms (2)
Standard care
ACTIVE COMPARATORChest tube drainage with hospital management * chest tube drainage (with a straight or pigtail drain, less than ≤ 14 Fr in diameter, inserted using the Seldinger versus Seldinger technique, or using the standard drainage technique with an internal mandrel drain), followed by post-procedure imaging prior to transfer to the department, in accordance with standard practice (chest X-ray or low-dose CT scan, depending on management practices at the center). * Hospitalisation in a hospital department (pulmonology, thoracic surgery, short-stay emergency unit, critical care, according to the usual pathway of the center in which the patient is included). * In-hospital monitoring until complete resolution of pneumothorax and drain removal (average 4-6 days).
Ambulatory management
EXPERIMENTAL\- Chest tube drainage in emergency department (Furhmann drain connected to Heimlich valve), connected to suction system at -5 to -10 cm H2O until bubbling stops and ambulatory management after monitoring in the emergency department
Interventions
* Chest tube drainage in emergency department (Furhmann drain connected to Heimlich valve), connected to suction system at -5 to -10 cm H2O until bubbling stops * Follow-up imaging at 4 hours (chest X-ray or low-dose CT scan, depending on management practices in the centers) * if the pneumothorax is still very large, or if clinical tolerance is unsatisfactory (dyspnea, unrelieved pain, abnormal vital parameters), the patient should be admitted to hospital * if the lung is in the process of reattachment and a minimal detachment persists, and clinical tolerance is good (assessed on vital parameters, with oxygen saturation above 98%, good hemodynamic stability and pain relieved by analgesics), the patient may be discharged home.
Hospitalisation in a hospital department (pulmonology, thoracic surgery, short-stay emergency unit, critical care, according to the usual pathway of the center in which the patient is included). In-hospital monitoring until complete resolution of pneumothorax and drain removal (average 4-6 days).
Eligibility Criteria
You may qualify if:
- Patients aged 18 to 50 years presenting to the emergency department with a 1st episode of right or left primary spontaneous pneumothorax (PSP) of large abundance diagnosed by chest X-ray or CT scan defined according to British Thoracic Society (BTS) recommendations as a detachment greater than 2 cm over the entire height of the axillary line.
- Patient living less than an hour from hospital and able to be accompanied for the first 48 hours
- Patient able to understand the aims and risks of the research and to give informed, dated and signed consent
- Patient with Internet access and able to complete online questionnaires
- Patient affiliated to or benefiting from a social health insurance
You may not qualify if:
- Small pneumothorax (≤ 2cm)
- Suffocating pneumothorax defined by the presence of signs of respiratory distress or hemodynamic failure with indication for emergency exsufflation
- Patient on emergency oxygen or long-term oxygen therapy
- Traumatic pneumothorax
- Secondary spontaneous pneumothorax
- Bilateral pneumothorax
- Associated fluid effusion
- Risk-benefit balance unfavorable to outpatient treatment (comorbidities, isolated patient, difficulty understanding monitoring instructions)
- Patient living more than one hour from hospital
- Patients living alone or unable to be accompanied on discharge for the first 48 hours
- Patients under legal protection
- Pregnant or breast-feeding women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
CHRU de Besançon - Hôpital Jean Minjoz
Besançon, 25030, France
Hôpital Pellegrin - CHU de Bordeaux
Bordeaux, 33000, France
CHU de Grenoble - Hôpital Michallon
La Tronche, 38700, France
Hôpital Saint Louis - AP-HP
Paris, 75475, France
Hôpital Universitaire Pitié Salpétrière AP-HP
Paris, 75651, France
Hôpital de la Milétrie - CHU de Poitiers
Poitiers, 86021, France
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67091, France
Related Publications (1)
Kepka S, Wilme V, Duracinsky M, Matau C, Nze Ossima A, Gil Jardine C, Le Borgne P, Marjanovic N, Marx T, Ohana M, Peyrony O, Philippon AL, Viglino D, Chenou A, Clere-Jehl R, Bilbault P, Durand-Zaleski I, Sauleau EA. Ambulatory management of primary spontaneous pneumothorax in the emergency department: EFFI-PNO protocol - a multicentre, cluster-controlled, stepped-wedge, randomised interventional study. BMJ Open. 2025 Dec 24;15(12):e106739. doi: 10.1136/bmjopen-2025-106739.
PMID: 41448686DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 14, 2024
First Posted
June 24, 2024
Study Start
December 1, 2025
Primary Completion (Estimated)
July 1, 2030
Study Completion (Estimated)
July 1, 2030
Last Updated
November 26, 2025
Record last verified: 2025-11